радиосенсибилизирующее means дл  combined лечени  oncological diseases

摘要

the invention u043eu0442u043du043eu0441u0438u0442u0441u00a0 to medicine, in particular to oncology, and one of the most urgent problems u043au0430u0441u0430u0435u0442u0441u00a0 her u043bu0435u0447u0435u043du0438u00a0 malignant tumors, including u043du0435u043eu043fu0435u0440u0430 u0431u0435u043bu044cu043du044bu0445.the treatment of this group of tumors, because of its low efficiency, u00a0u0432u043bu00a0u0435u0442u0441u00a0 u043eu0431u0448u0435u0431u0438u043eu043bu043eu0433u0438u0447u0435u0441u043au043eu0439 problem, and proposed a way u043bu0435u0447u0435u043du0438u00a0 based on comb the kinetics of u0438u043du0438u0440u043eu0432u0430u043du043du043eu043c u0434u0435u043bu0435u043du0438u00a0 tumor cells.qi - u0442u043eu0441u0442u0430u0442u0438u0447u0435u0441u043au043eu043c and u0440u0430u0434u0438u043eu0441u0435u043du0441u0438u0431u0448u0448u0437u0438u0440u0443u044eu0449u0435u043c effects of new national drug u043fu0440u043eu043au0441u0438u0444u0435u0438u043du0430 provides a significant increase in the efficiency of u0445u0438u043cu0438u043eu0442u0435u0440 u0430u043fu0435u0432u0442u0438 technical and ray u0430u043du0442u0438u0431u043bu0430u0441u0442u0438u0447u0435u0441u043au043eu0433u043e u0432u043eu0437u0434u0435u0439u0441u0442u0432u0438u00a0 on tumor. while reducing the dose, t. e. u043bu0435u0447u0435u043du0438u00a0 toxicity and dose u043eu0431u043bu0443u0447u0435u043du0438u00a0, t. e.u0443u0433u0440u043eu0437u044bu0440u0430u0434u0438u043eu043du0435u043au0440u043eu0437u0430 provides multiple very u043bu0435u0447u0435u043du0438u00a0 and, therefore, u043fu0440u043eu043bu043eu043du0433u0438u0440u043eu0432u0430u043du0438u00a0 en u0442u0438u0431u043bu0430u0441u0442u043eu043cu0430u0442u043eu0437u043du043eu0433u043e effect and u0443u0432u0435u043bu0438u0447u0435u043du0438u00a0 about u0434u043eu043bu0436u0438u0442u0435u043bu044cu043du043eu0441u0442u0438 life patients. c / 5 d (bJ o h os 4